Displaying 221 - 230 of 530
Lipodystrophy is a rare, heterogeneous group of syndromes characterized by the complete or partial loss or absence of subcutaneous adipose tissue. This consensus statement provides an overview of the literature and expert opinion on recognizing lipodystrophy and some potential management strategies.
Read Consensus Statement more Co-sponsored by the Associazione Medici Endocrinologi
This consensus statement describes the Thyroid Nodule App (termed TNAPP), a novel interactive web-based tool that uses clinical, imaging, cytologic, and molecular marker data to guide clinical decision making to evaluate and manage thyroid nodules.
Read Consensus Statement
more
Co-sponsored by the Associazione Medici Endocrinologi
This guideline covers diagnostic and therapeutic aspects of thyroid nodular disease but not thyroid cancer management. Suggestions for thyroid nodule management during pregnancy and childhood are also included.
Read Guideline
more
Co-sponsored by the American Thyroid Association
This guideline provides recommendations for diagnosis and clinical management of patients with hypothyroidism in the ambulatory care setting.
Read Guideline
more
Co-sponsored by the American Thyroid Association
This guideline provides evidence-based recommendations for the management of patients with thyrotoxicosis.
Read Guideline
more
This algorithm for the comprehensive management of dyslipidemia and prevention of cardiovascular disease (CVD) complements the 2017 AACE Guideline for Management of Dyslipidemia and Prevention of Cardiovascular Disease and provides clinicians with a practical guide that considers the whole patient, their spectrum of risks and complications, and evidence-based approaches to treatment. An update to this algorithm will be available in late 2025.
Read Consensus Statement
…
moreThis clinical practice guideline provides evidence-based recommendations to reduce the risks and consequences of dyslipidemia. It provides guidance on screening, risk assessment, and treatment recommendations for a range of individuals with various lipid disorders. The recommendations emphasize the importance of treating low-density lipoprotein cholesterol (LDL-C) in some individuals to lower goals than previously endorsed and support the measurement of coronary artery calcium scores and inflammatory markers to help stratify risk. Special consideration is given to individuals with diabetes,…
moreThis consensus statement identifies common technical errors and issues that can affect DXA report conclusions and provides guidance on how to address those issues to ensure that patients receive appropriate osteoporosis care.
Read Consensus Statement moreThis position statement addresses the use of dietary supplements on skeletal health, the need for more studies that accurately quantify the effect of an individual nutrient on bone health, the importance of recognizing the nutrient needs of each individual, and current understanding of optimal nutrition to maximize bone gain, minimize bone loss, and reduce fragility fracture risk.
Read Position Statement moreThis updated guideline provides recommendations for the care and management of people with or at risk for diabetes mellitus at every stage, including prevention, diagnosis, and treatment.
Read Guideline
The authors of the guideline identified a few errata. Download the corrigendum to learn about changes that reflect up-to-date best practice.
Download Corrigendum
The…
more
